2024-03-31-accounts - Getgenome

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

Trustees' Annual Report for the period

Period start date 18 11 2022

Period end date 31 03 2024

From To

Section A Reference and administration details

GetGenome

Charity name GetGenome Other names charity is known by Registered charity number (if any) 1201069 Charity's principal address THE SAINSBURY LABORATORY COLNEY LANE, COLNEY NORWICH Postcode NR4 7UH

Names of the charity trustees who manage the charity

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20	Trustee name	Office (if any)	Dates acted if not for whole year	Name of person (or body) entitled to appoint trustee (if any)
	Nicolas Jose Talbot
	Saskia Adriane Hogenhout
	Sophien Kamoun
	Appolinaire Djikeng

Names of the trustees for the charity, if any, (for example, any custodian trustees)

Name Dates acted if not for whole year

March 2012

TAR

Names and addresses of advisers (Optional information)

Type of adviser Name Address

Name of chief executive or names of senior staff members (Optional information)

Section B Structure, governance and management

Description of the charity’s trusts

Type of governing document

Constitution

(eg. trust deed, constitution)

How the charity is constituted

Charitable Incorporated Organisation

(eg. trust, association, company)

Trustee selection methods

Appointed by existing trustees

(eg. appointed by, elected by)

Additional governance issues (Optional information)

You may choose to include additional information, where relevant, about:

policies and procedures adopted for the induction and training of trustees;
the charity’s organisational structure and any wider network with which the charity works;
relationship with any related parties;
trustees’ consideration of major risks and the system and procedures to manage them.

Section C Objectives and activities

Summary of the objects of the charity set out in its governing document

The objects of the CIO are to advance science and education through the provision of equitable access to genomics technology and related training for the public benefit (and particularly amongst scientists) in all aspects of that subject.

March 2012

TAR

GetGenome provides support for scientists throughout the global south by providing training in the field of genomics and open science publishing. GetGenome’s empowerment of researchers strengthens local research capabilities and enables advancements in scientific knowledge that contribute to the global public good. GetGenome supports research across a variety of life science fields and has built valuable networks to support researchers’ learning and collaboration potential.

Summary of the main activities undertaken for the public benefit in relation to these objects (include within this section the statutory declaration that trustees have had regard to the guidance issued by the Charity Commission on public benefit)

The Trustees have taken due regard to the commission’s public benefit guidance when exercising their powers and duties as set out in the Charities Regulation 2008.

During the reporting period GetGenome has supported researchers in Tunisia and Mexico leading to enhanced capacity and the dissemination of novel science to the community. GetGenome has also engaged with training and network building in Zambia and Bangladesh during the reporting period. This work focusses on the surveillance of damaging wheat diseases in the region.

Additional details of objectives and activities (Optional information)

You may choose to include further statements, where relevant, about:

policy on grantmaking;
policy programme related investment;
contribution made by volunteers.

March 2012

TAR

Section D Achievements and performance

Summary of the main achievements of the charity during the year

Engaged >50 researchers in genomics and open science training in Tunisia, Mexico, Zambia and Bangladesh. Provided support for the awardees-researchers to published 20 pre-print research articles within a GetGenome pre-print community. Built a network of researchers to further enhance their learning and collaboration opportunities.

March 2012

TAR

Section E Financial review

Our charity maintains reserves proportional to operational costs to ensure Brief statement of the continuity in times of financial uncertainty. These funds are safeguarded charity’s policy on reserves to support essential activities during unforeseen challenges, sustaining our mission and the impact of our programs

Details of any funds materially in deficit

None

Further financial review details (Optional information)

You may choose to include additional information, where relevant about:

the charity’s principal sources of funds (including any fundraising);
how expenditure has supported the key objectives of the charity;
investment policy and objectives including any ethical investment policy adopted.

Section F Other optional information

Section G Declaration

The trustees declare that they have approved the trustees’ report above.

Signed on behalf of the charity’s trustees

Signature(s) Full name(s) Sophien Kamoun FRS Position (eg Secretary, Chair, Trustee, co-founder etc) Date November 14th, 2024

March 2012

TAR

Charity Name No (if any) GetGenome 1201069 Receipts and payments accounts For the period Period start date Period end date To from 18/11/2022 31/03/2024

Section A Receipts and payments

A1 Receipts	Unrestricted funds to the nearest £	Restricted funds to the nearest £	Endowment funds to the nearest £	Total funds to the nearest £ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
	-	-	-	-
	-	-	-	-
	-	-	-	-
	-	-	-	-
	-	-	-	-
	-	-	-	-
	-	-	-	-
	-	-	-	-
*Sub total*(Gross income for AR)	-	-	-	-

A2 Asset and investment sales, (see table).
	-
	-
*Sub total*	-
*Total receipts* A3 Payments
	-	-	-	-
	-	-	-	-
	-	-	-	-
	-	-	-	-
	-	-	-	-
	-	-	-	-
	-	-	-	-
	-	-	-	-
	-	-	-	-
**Sub total **	-	-	-	-

A4 Asset and investment purchases, (see table)
	-
	-
**Sub total **	-
*Total payments* *Net of receipts/(payments)* A5 Transfers between funds A6 Cash funds last year end *Cash funds this year end*
	-			-
	-			-
	-			-
	-			-

CCXX R1 accounts (SS)

14/11/2024

Section B Statement of assets and liabilities at the end of the period

Categories B1 Cash funds B2 Other monetary assets B4 Assets retained for the charity’s own use B5 Liabilities B3 Investment assets	Details Details Details Details *Total cash funds* (agree balances with receipts and payments account(s)) Details	Unrestricted funds to nearest £ - - - - OK Unrestricted funds to nearest £ - - - - - - Fund to which asset belongs Fund to which asset belongs Fund to which liability relates	Restricted funds to nearest £
			-
			-
			-
			-
			OK
			Restricted funds to nearest £
			-
			-
			-
			-
			-
			-
			Cost (optional)
			-
			-
			-
			-
			-
			Cost (optional)
			-
			-
			-
			-
			-
			-
			-
			-
			-
			Amount due (optional)
			-
			-
			-
			-
			-

Signed by one or two trustees on behalf of all the trustees

Signature

Print Name

Sophien Kamoun FRS

CCXX R2 accounts (SS)

14/11/2024

----- Start of picture text -----
CC16a
----- End of picture text -----

----- Start of picture text -----
Last year
----- End of picture text -----

to the nearest £ - - - - - - - - -

CCXX R3 accounts (SS)

14/11/2024

----- Start of picture text -----
Endowment
funds
to nearest £
----- End of picture text -----

OK Endowment funds to nearest £

Current value (optional)

When due (optional)

Date of approval

14/11/2024

CCXX R4 accounts (SS)

14/11/2024